- Home
- ROIV vs LAD Comparison
ROIV vs LAD Comparison
Compare ROIV & LAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- LAD
- Stock Information
- Founded
- ROIV 2014
- LAD 1946
- Country
- ROIV United Kingdom
- LAD United States
- Employees
- ROIV N/A
- LAD N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- LAD Retail-Auto Dealers and Gas Stations
- Sector
- ROIV Health Care
- LAD Consumer Discretionary
- Exchange
- ROIV Nasdaq
- LAD Nasdaq
- Market Cap
- ROIV 8.4B
- LAD 7.6B
- IPO Year
- ROIV N/A
- LAD 1996
- Fundamental
- Price
- ROIV $10.76
- LAD $326.23
- Analyst Decision
- ROIV Buy
- LAD Strong Buy
- Analyst Count
- ROIV 4
- LAD 13
- Target Price
- ROIV $17.50
- LAD $375.15
- AVG Volume (30 Days)
- ROIV 5.9M
- LAD 336.6K
- Earning Date
- ROIV 05-29-2025
- LAD 04-23-2025
- Dividend Yield
- ROIV N/A
- LAD 0.67%
- EPS Growth
- ROIV N/A
- LAD N/A
- EPS
- ROIV N/A
- LAD 31.74
- Revenue
- ROIV $122,585,000.00
- LAD $36,804,700,000.00
- Revenue This Year
- ROIV N/A
- LAD $8.04
- Revenue Next Year
- ROIV N/A
- LAD $7.36
- P/E Ratio
- ROIV N/A
- LAD $10.27
- Revenue Growth
- ROIV 140.04
- LAD 12.81
- 52 Week Low
- ROIV $8.73
- LAD $243.04
- 52 Week High
- ROIV $13.06
- LAD $405.68
- Technical
- Relative Strength Index (RSI)
- ROIV 49.33
- LAD 65.70
- Support Level
- ROIV $10.58
- LAD $292.97
- Resistance Level
- ROIV $11.77
- LAD $329.26
- Average True Range (ATR)
- ROIV 0.34
- LAD 8.35
- MACD
- ROIV -0.05
- LAD 4.09
- Stochastic Oscillator
- ROIV 15.13
- LAD 86.22
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About LAD Lithia Motors Inc.
Lithia Motors is a retailer of new and used vehicles and related services. The company offers over 50 brands of vehicles at nearly 500 stores globally across the US, Canada, and UK. The company has expanded largely through the acquisition of dealerships in smaller regional markets but now seeks to grow in any part of the US and we expect more deals over time in the US and, at times, abroad. Annual revenue in 2024 was $36.2 billion and we see over $50 billion possible in a few years. The US was 78% of 2024 revenue and the UK second at 19%, due to the 2024 Pendragon acquisition. In 2024, new vehicle sales were about 49% of total revenue. Lithia was founded in 1946, went public in 1996, and is the largest US auto dealer. It is based in Medford, Oregon.